MDT — pipeline value the Street ignores
Subscribers get the full thesis, the levels, and my positioning on MDT. Subscribe to read on.
3 notes · 9 subscribers · publishing since May 2026
Med-tech adoption curves and pharma pipelines. Durable healthcare compounding, less binary risk.
Subscribers get the full thesis, the levels, and my positioning on MDT. Subscribe to read on.
The risk/reward into the readout is asymmetric if you size the basket right.
Pipeline option value is being given away at the current multiple.
Free posts land in your feed either way.
Cancel anytime. Free posts stay free either way.
The verified record above is public. Subscribe to see live calls as they open — entry, conviction, settlement, and the full thesis.
Each bar is one closed option call's modeled return, oldest to newest. Premiums are modeled with Black-Scholes from the live underlying + its historical volatility, and settle at intrinsic value on expiry — a consistent estimate, not exact traded fills.
Opinion. The author may or may not hold positions discussed. Not advice. Not a financial promotion approved under FSMA s.21. Quote data is delayed. Figures are computed automatically from third-party market data and may contain errors; option figures are modeled, not traded fills. Past performance is not a reliable indicator of future results.